Ameritas Advisory Services’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
PHS
GIM
PAMS
BBA
Ameritas Advisory Services's BLUE Position: Q2 2023 in Review
Ameritas Advisory Services sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 35 shares — an estimated $2.41K sold.
Ameritas Advisory Services first reported a position in BLUE in Q1 2023 and held it in 1 quarter. The position peaked at $2.41K in Q1 2023. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.
- Ameritas Advisory Services reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
- Ameritas Advisory Services sold 35 bluebird bio shares in Q2 2023, an estimated $2.41K.
- Ameritas Advisory Services first reported a position in bluebird bio in Q1 2023 and held it in 1 quarter.
- Ameritas Advisory Services's bluebird bio position peaked at $2.41K in Q1 2023.
- 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.
Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.